DTaP vaccine paediatric - Prosper Channel Lifescience India

Drug Profile

DTaP vaccine paediatric - Prosper Channel Lifescience India

Alternative Names: Diphtheria tetanus-acellular pertussis vaccine - Prosper Channel Lifescience India; Diphtheria tetanus-acellular pertussis vaccine paediatric - Prosper Channel Lifescience India; DTaP vaccine - Prosper Channel Lifescience India

Latest Information Update: 18 Feb 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Prosper Channel Lifescience India
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Diphtheria; Pertussis; Tetanus

Most Recent Events

  • 17 Feb 2016 Discontinued - Phase-III for Diphtheria (In infants) in India (IM)
  • 17 Feb 2016 Discontinued - Phase-III for Pertussis (In infants) in India (IM)
  • 17 Feb 2016 Discontinued - Phase-III for Tetanus (In infants) in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top